Funds · 13F filer · St. Helier, Y9

Medicxi Ventures Management (Jersey) Ltd

$177.4M in 3 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

Returns–Not enough quarters yet

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
PHATPhathom Pharmaceuticals Inc$81.0M45.6%
Newamsterdam Pharma CompanyCUSIP N62509109$74.9M42.2%−17.4%
AURAAura Biosciences Inc$21.6M12.2%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
Newamsterdam Pharma CompanyCUSIP N62509109December 31, 2022+222.1%$74.9M
AURAAura Biosciences IncDecember 31, 2021−58.2%$21.6M
PHATPhathom Pharmaceuticals IncJune 30, 2020−67.0%$81.0M

Sold off last quarter

  • Centessa Pharmaceuticals PLCCUSIP 152309100 was $792.9M

Quarter by quarter

QuarterIts picksS&P 500
March 31, 2026+33.5%−4.6%
December 31, 2025+12.2%+2.4%
September 30, 2025+66.1%+7.8%
June 30, 2025−1.3%+10.5%
March 31, 2025−17.3%−4.6%
December 31, 2024−6.6%+2.1%
September 30, 2024+57.8%+5.4%
June 30, 2024−10.0%+4.0%
March 31, 2024+44.9%+10.0%
December 31, 2023+15.6%+11.2%
September 30, 2023−8.4%−3.6%
June 30, 2023+43.7%+8.3%
March 31, 2023−1.7%+7.0%
December 31, 2022−1.4%+7.1%
September 30, 2022+0.7%−5.3%
June 30, 2022−34.8%−16.5%
March 31, 2022−11.7%−4.9%
December 31, 2021−24.8%+10.7%
September 30, 2021−17.6%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1715579
  2. 2
    Filed August 4, 2026 · accession 0001193125-26-332000